VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 920655
AUDUBON, PA
Position in SPRY
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$668,296
-$301,275 QoQ
Shares Held
83,225
0.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
5.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VALLEY FORGE INVESTMENT CONSULTANTS INC ADV holds $961,217 across 2 Biotechnology names. SPRY ranks #1 (69.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
83,225 | $668,296 | |
| 2 | NGEN |
Nervgen Pharma Corp.
|
77,698 | $292,921 |
All Filings in SPRY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $668,296 | 83,225 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $969,571 | 83,225 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $836,411 | 83,225 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,452,276 | 83,225 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,046,970 | 83,225 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $878,023 | 83,225 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,206,762 | 83,225 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||